Conference: 16th Annual World ADC London 2026
Date: February 23 - 26, 2026
Location: London
Where to hear Certara insights and expertise
Piet van der Graaf, PharmD, PhD, Senior Vice President and Head of Quantitative Systems Pharmacology, will participate in a panel discussion on how Model-Informed Drug Development (MIDD) accelerates ADC discovery and development. The session will highlight Certara’s ADC EFA platform, showcase real-world case studies, and reference research from Eline van Maanen, Director, on pharmacometric approaches for ADCs.
Meet the Certara team
Experts from clinical pharmacology, pharmacometrics, and Quantitative Systems Pharmacology (QSP) will be available throughout the meeting to discuss your ADC program, from early feasibility and translational modeling through pivotal strategy and regulatory submissions.
Meet us there
Connect with Certara’s global ADC experts at World ADC to explore end-to-end support for discovery, clinical development, and global regulatory filings. Bring your ADC challenges and leave with a clear, data-driven path forward.
